Why Tandem Diabetes Care, Inc.’s (TNDM) Stock Is Up 7.36%
As of Thursday, July 16, Tandem Diabetes Care, Inc.’s TNDM share price has surged by 7.36%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Rosalio Madrigal
Cynthia McLaughlin
Rosalio Madrigal
| Share Statistics | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,303.1 | $334.8 | 49% |
|
| Shares Out (Mil) | 68.4 | 41.7 | 55% |
|
| Institutional Ownership | 98.9% | 77.3% | 83% |
|
| Float (Mil) | 62.9 | 34.7 | 53% |
|
| Beta | 1.64 | 0.86 | 86% |
|
| Avg Daily Volume (000s) | 1,697 | 266 | 79% |
|
| Price Change (52-week) |
13.9% | 60.7% | 57% |
|
| Growth | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.3% | 11.8% | 74% |
|
| Net Income (5yr) | (42.9%) | (5.8%) | 8% |
|
| EPS (5yr) | (40.1%) | 10.7% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.7%) | (16.1%) | 55% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 18 | 19 | 19 | |
| Current EPS | ($0.319) | ($0.685) | $0.107 | |
| Month Ago EPS | ($0.326) | ($0.707) | $0.078 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($0.294) | ($0.801) | ($0.027) | |
| Year/Year Chg | 7.0% | (77.5%) | (125.0%) | |
| Financials | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,028 | $152 | 51% |
|
| Net Income (TTM) (Mil) | ($95) | ($11) | 11% |
|
| EPS (TTM) | ($1.395) | ($0.500) | 18% |
|
| Operating Cash Flow (TTM) (Mil) | $20 | ($2) | 41% |
|
| Net Cash Flow (TTM) (Mil) | $126 | $1 | 80% |
|
| Long-Term Debt (Q1) (Mil) | $715 | $22 | 63% |
|
| Enterprise Value (Q1) (Mil) | $1,225 | $304 | 43% |
|
| Valuation | TNDM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.85 | 2.88 | 90% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.9% | 59.1% | 67% |
|
| Net Margin | (9.2%) | (7.7%) | 21% |
|
| ROA | (9.1%) | (13.7%) | 26% |
|
| ROE | (65.7%) | (15.9%) | 13% |
|
| Liabilities to Assets | 88.5% | 44.9% | 83% |
|
| F-Score | 5 | 4 | 51% |
|
Tandem Diabetes Care, Inc. did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors